Immatics N.V. Ordinary Shares (IMTX)
Immatics N.V. Ordinary Shares
XNAS:IMTX
10.26
$12.48 - 60.00
$10.00 - 2.00
$10.17
$10.59
$10.49
$10.69
11.25
3.3
428240
582805.8
95954730.3
Chart
TendieTensor AI Analysis
Company
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Fundamentals
423
-9.380000
2.654250
-0.42
100
121.55M
121.56M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own IMTX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.